A pilot study optimizing metabolomic and lipidomic acquisition in serum for biomarker discovery in nonalcoholic fatty liver disease
Background: The worldwide prevalence of non-alcoholic fatty liver disease (NAFLD) has stimulated work to identify biomarkers and develop effective treatments. Metabolomics is an emerging tool that has been widely applied to discover biomarkers and simultaneously uncover pathological mechanisms. Here...
| Автори: | , , , , , |
|---|---|
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
Elsevier
2021-11-01
|
| Серія: | Journal of Mass Spectrometry and Advances in the Clinical Lab |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2667145X21000213 |